Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lombard appoints new money man

This article was originally published in Clinica

Executive Summary

Endovascular stent graft specialist Lombard Medical has appointed William Kullback chief financial officer. Mr Kullback has over 30 years’ corporate finance and accounting experience, including more than 20 years in CFO roles in both large publicly-traded and privately held companies. He replaces Ian Ardill, who had been with Lombard since 2012. The personnel change comes after Lombard moved its listing from the UK’s AIM market to Nasdaq stock exchange in the US in April. The company’s flagship Aorfix endovascular stent graft for treating abdominal aortic aneurysms is both US FDA-approved and CE-marked.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102179

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel